Related MeSH Hierarchy (4)
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Anemia » Anemia, Hemolytic » Anemia, Hemolytic, Congenital » Thalassemia » beta-Thalassemia
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Hemoglobinopathies » Thalassemia » beta-Thalassemia
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Genetic Diseases, Inborn » Anemia, Hemolytic, Congenital » Thalassemia » beta-Thalassemia
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Genetic Diseases, Inborn » Hemoglobinopathies » Thalassemia » beta-Thalassemia
Description
A disorder characterized by reduced synthesis of the beta chains of hemoglobin. There is retardation of hemoglobin A synthesis in the heterozygous form (thalassemia minor), which is asymptomatic, while in the homozygous form (thalassemia major, Cooley's anemia, Mediterranean anemia, erythroblastic anemia), which can result in severe complications and even death, hemoglobin A synthesis is absent. MeSH
Hierarchy View
Approved Indicated Drugs (3)
Phase 4 Indicated Drugs (19)
Phase 2 Indicated Drugs (34)
Other Experimental Indicated Drugs (14)
Organization Involved with Phase 4 Indications (26)
Organization Involved with Phase 3 Indications (17)
Organization Involved with Phase 2 Indications (71)
Azienda Ospedaliera Villa Sofia
Case Western Reserve University
Children's National Medical Center
Laikο General Hospital, Athens
La Jolla Pharmaceutical Company
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institutes of Health (NIH)
Rare Partners srl Impresa Sociale
Shanghai Bioray Laboratory Inc.
The Oncology Institute Long Beach
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (10)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.